Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring nVision Medical, a developer of a device for collecting cells from the fallopian tubes to detect ovarian cancer. Ovarian cancer is the fifth leading cause of cancer death among women. More than 2 million women in the U.S. are at high risk and it …

With its acquisition of Orthotaxy, Johnson & Johnson joins a growing list of medtech players strengthening surgical robotics offerings expanding the technology’s applications.  Orthotaxy’s is in early-stage development for total and partial knee replacement.  The deal helps J&J compete more effectively against Stryker’s Mako orthopedic surgical solution, acquired in 2013. In 2015, J&J’s Ethicon unit partnered with Verily, Google’s life sciences unit, to form Verb, …

Roche Holding AG, a $54.1b research-focused, biotechnology company is acquiring Flatiron Health, a developer of an OncologyCloud platform which includes medical record for oncology, advanced analytics, patient portal and integrated billing for $1.9b. Flatiron’s cancer-centric electronic health records platform is connected to about 250 community oncology practices; it has a partnership with the National Cancer Institute (NCI), a part of the National Institutes …

Allergan Plc, a $15.9b provider of medical aesthetics, biosimilars, and over-the-counter pharmaceutical products will acquire Elastagen Pty Ltd., a provider of advanced tissue repair platform based on tropoelastin (gives tissue its elasticity) for $95m. The acquisition adds proprietary injectable products to Allergan’s existing portfolio. Elastagen’s technology is based on human tropoelastin, the precursor of elastin which is a key component of youthful skin. …

Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring Millipede, Inc., a developer of transcatheter, semi-rigid, complete annuloplasty ring for the treatment of heart disease for $90m. Millipede IRIS’ annuloplasty ring which is delivered via a transcatheter-transseptal delivery system repairs and reduce the size of a dilated mitral annulus. The IRIS device is a …

Wright Medical Group N.V, a $720.4m developer of specialty orthopedics focused on extremity and biologic solutions is acquiring Imascap SAS, a developer preoperative planning of shoulder replacement surgery software for $62.50m plus $26.30m in milestones. The deal accelerates Wright Medical’s product portfolio and leverages its extremities business. IMASCAP’s Glenosys technology allows surgeon to simulate the position of a shoulder prosthesis using CT image …

CVS Health Corporation to acquire Aetna for $69b CVS Health Corporation, a $180.7b retail pharmacy and health care company has agreed to buy Aetna, a $61.4b managed health care company, which sells traditional and consumer directed health care insurance plans and related services for $69b. The combination creates a comprehensive health-care platform for consumers by offering a community-based health hub …

Ambu already operates in the field of single-use pulmonary endoscopy (visualization of the airways) of which there are approximately 5 million procedures annually. With the acquisition of Invendo Medical, Ambu enters the field of gastrointestinal endoscopy (visualization of the stomach and intestines) of which there are approximately 70 million procedures annually. Advanced reusable medical devices are difficult to sterilize and …

The Walden Group is pleased to announce that it represented Attentus Medical Sales, Inc.,a provider of specialized products to compounding, specialty, and infusion pharmacies, to Medical Specialty Distributors, LLC, a leading alternate site patient supply chain solutions provider and a portfolio company of New Mountain Capital.

The Walden Group is pleased to announce that it represented Millennium Surgical Corp. in its sale to Avalign Technologies, Inc.